Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
La Jolla, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Inhibrx Biosciences, Inc. has filed 132 SEC EDGAR filings since 29 Jan 2024

SEC filing history

Showing 51-75 of 132 matching filings.

Per page
25
Current page
3
3

FORM 3

Filing date
02 Apr 2025
Reporting date
01 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-280127

424B3

Filing date
01 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Mar 2025
Reporting date
27 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
POS EX File 333-280127

POS EX

Filing date
17 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-280127

424B3

Filing date
17 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-94527

SCHEDULE 13D/A filing

Filing date
26 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-94527

SCHEDULE 13D/A filing

Filing date
26 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-94527

SCHEDULE 13G filing

Filing date
04 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-280127

424B3

Filing date
21 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-280127

424B3

Filing date
13 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Dec 2024
Reporting date
16 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Dec 2024
Reporting date
06 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Nov 2024
Reporting date
19 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94527

SC 13G

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-280127

424B3

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-280127

424B3

Filing date
04 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Oct 2024
Reporting date
03 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .